Aardvark Therapeutics (AARD)Insider bought ~$3M

~$3M

Approx. value · 188K sh @ $16.00

988K

Holds after · shares reported

Traded

Feb 14, 2025

Filed

Feb 19, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 14, 2025 · this disclosureInsiderInsider purchased ~$3M of AARD shares in the open market

What came next

1. Feb 14, 2025Insider · 3 peopleInsiders: 4 purchases (~$20.4M)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Aardvark Therapeutics

OQRO holds no insider, Congress, fund or contract record for Aardvark Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AARD page.

Other recent filings by Cormorant Asset Management, LP, Reporting person

• SEC Form 4 at Bright Minds Biosciences (DRUG)Apr 30, 2026
• SEC Form 4 at Onkure Therapeutics (OKUR)May 19, 2025
• SEC Form 4 at Onkure Therapeutics (OKUR)May 14, 2025
• SEC Form 4 at Bright Minds Biosciences (DRUG)Nov 6, 2024
• SEC Form 4 at Bright Minds Biosciences (DRUG)Oct 17, 2024

The full history of Cormorant Asset Management, LP, Reporting person is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Aardvark Therapeutics

• SEC Form 4Sep 16, 2025
• SEC Form 4Sep 16, 2025
• SEC Form 4Sep 13, 2025
• SEC Form 4Sep 13, 2025
• SEC Form 4Sep 13, 2025
• SEC Form 4Sep 10, 2025

Everything OQRO holds on this company is on its AARD page.